These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 488008)

  • 21. Effects of arginine and arginine plus somatostatin infusion on insulin release in diabetic patients submitted to pancreas allotransplantation.
    Secchi A; Pontiroli AE; Bosi E; Piatti PM; Touraine JL; Monti LD; Gelet A; Traeger J; Dubernard JM; Pozza G
    Diabete Metab; 1987; 13(4):422-5. PubMed ID: 2890540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperglycemia and beta-cell adaptation during prolonged somatostatin infusion with glucagon replacement in man.
    Ward WK; Halter JB; Best JD; Beard JC; Porte D
    Diabetes; 1983 Oct; 32(10):943-7. PubMed ID: 6137430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of glycemic potentiation. Sensitive indicator of beta-cell loss in partially pancreatectomized dogs.
    Ward WK; Wallum BJ; Beard JC; Taborsky GJ; Porte D
    Diabetes; 1988 Jun; 37(6):723-9. PubMed ID: 3289992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physiological concentrations of cholecystokinin stimulate amino acid-induced insulin release in humans.
    Rushakoff RJ; Goldfine ID; Carter JD; Liddle RA
    J Clin Endocrinol Metab; 1987 Sep; 65(3):395-401. PubMed ID: 3305550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.
    Ishida T; Röjdmark S; Bloom G; Chou MC; Field JB
    Endocrinology; 1980 Jan; 106(1):220-30. PubMed ID: 7349954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phentolamine and the action of somatostatin in man.
    Schmitt JK; Lorenzi M; Gerich JE; Bohannon NV; Karam JH; Forsham PH
    J Clin Endocrinol Metab; 1979 May; 48(5):880-2. PubMed ID: 219013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of somatostatin in the Syrian hamster bearing a transplantable islet-cell tumor.
    Luyckx AS; Lefebvre PJ
    Horm Metab Res; 1978 Mar; 10(2):105-10. PubMed ID: 206496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant deoxyribonucleic acid-derived 22K- and 20K-human growth hormone generate equivalent diabetogenic effects during chronic infusion in dogs.
    Ader M; Agajanian T; Finegood DT; Bergman RN
    Endocrinology; 1987 Feb; 120(2):725-31. PubMed ID: 3542508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and effects of intravenous infusion of somatostatin in normal subjects--a two-compartment open model.
    Ho LT; Chen RL; Chou TY; Fong JC; Wang PS; Chou CK
    Clin Physiol Biochem; 1986; 4(4):257-67. PubMed ID: 2875821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Somatostatin inhibition of pancreatic glucagon release from monolayer cultures and interactions with calcium.
    Wollheim CB; Blondel B; Renold AE; Sharp GW
    Endocrinology; 1977 Sep; 101(3):911-9. PubMed ID: 330154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of glucose per se to intravenous glucose tolerance. Comparison of the minimal-model prediction with direct measurements.
    Ader M; Pacini G; Yang YJ; Bergman RN
    Diabetes; 1985 Nov; 34(11):1092-103. PubMed ID: 2864297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
    Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
    J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-insulin-mediated glucose uptake predominates in postabsorptive dogs.
    Lavelle-Jones M; Scott MH; Kolterman O; Moossa AR; Olefsky JM
    Am J Physiol; 1987 May; 252(5 Pt 1):E660-6. PubMed ID: 2883896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormonal and metabolic effects of near physiological increase of plasma immunoreactive somatostatin 14.
    Souquet JC; Rambliere R; Riou JP; Beylot M; Cohen R; Mornex R; Chayvialle JA
    J Clin Endocrinol Metab; 1983 May; 56(5):1076-9. PubMed ID: 6131904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of nicotinic acid on plasma glucose concentration in normal individuals.
    Landau C; Chen YD; Skowronski R; Hollenbeck CB; Jaspan JB; Reaven GM
    Horm Metab Res; 1992 Sep; 24(9):424-8. PubMed ID: 1358776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of islet function to insulin action in human obesity.
    Beard JC; Ward WK; Halter JB; Wallum BJ; Porte D
    J Clin Endocrinol Metab; 1987 Jul; 65(1):59-64. PubMed ID: 3294880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for a synergistic effect of somatostatin on vasoactive intestinal polypeptide-induced prolactin release in the rat: comparison with its effect on thyrotropin (TSH)-releasing hormone-stimulated TSH release.
    Michalkiewicz M; Suzuki M; Kato M
    Endocrinology; 1987 Jul; 121(1):371-7. PubMed ID: 2885177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatostatin secretion from monolayer cultures of neonatal rat pancreas.
    Patel YC; Amherdt M; Orci L
    Endocrinology; 1979 Mar; 104(3):676-9. PubMed ID: 220017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arginine infusion increases peripheral plasma somatostatin in man.
    Skare S; Hanssen KF; Kriz V; Torjesen PA
    Clin Endocrinol (Oxf); 1984 Sep; 21(3):299-308. PubMed ID: 6148165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatostatin impairs clearance of exogenous insulin in humans.
    Ipp E; Sinai Y; Bar-Oz B; Nesher R; Cerasi E
    Diabetes; 1987 May; 36(5):673-7. PubMed ID: 2883058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.